Refine by MP, party, committee, province, or result type.
Health committee To address the issue of non-prescription drugs, our organization has an expert advisory committee that reviews non-prescription drugs and determines conditions of sale, which is a provincial authority. Those different conditions of sale would be a pharmacist-only sale—a pharmacis
February 14th, 2008Committee meeting
Karen Wolfe
Health committee My understanding of the current regulations is that they can strongly suggest to manufacturers that they take their product off the market once serious adverse reactions are reported, yet they do not have the regulatory power at this point in time to mandate it. I think that wo
February 14th, 2008Committee meeting
Karen Wolfe
Health committee In the same regard, in my experience in attending some of the progressive licensing workshops and getting a better understanding of what it means, from my perspective, it doesn't seem as if this is going to take away anything from the pre-market. However, it's going to add to the
February 14th, 2008Committee meeting
Karen Wolfe
Health committee The National Association of Pharmacy Regulatory Authorities is honoured to appear before this committee today. Our organization represents most of the provincial and territorial pharmacy regulatory authorities. During this presentation I'll be speaking to the role of the pharmac
February 14th, 2008Committee meeting
Karen Wolfe